ArticlePharmacotherapy2024

Cardiovascular adverse events in patients with hepatocellular carcinoma receiving vascular endothelial growth factor inhibitors.

Fangzheng Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.